Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shugan Wendan Decoction for Metabolic Syndrome
ChiCTR2100044912Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of Shugan Wendan Tang in cardiometabolic risk (CMR) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Blood lipids. Started Sep 2020; status: recruiting.
02
Drugs
Shugan Wendan Tang
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR2100044912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044912.